Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Balasubramaniam Website

Sanjeeve Balasubramaniam, M.D., M.P.H.

Selected Publications

1)  O'Sullivan C, Edgerly M, Velarde M, Wilkerson J, Venkatesan AM, Pittaluga S, Yang SX, Nguyen D, Balasubramaniam S, Fojo T.
The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.
J. Clin. Endocrinol. Metab. [Epub ahead of print], 2014.
2)  Jakopovic M, Thomas A, Balasubramaniam S, Schrump D, Giaccone G, Bates SE.
Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy.
Front Oncol. 3: 261, 2013.
3)  Balasubramaniam S, Ron E, Gridley G, Schneider AB, Brenner AV.
Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.
J. Clin. Endocrinol. Metab. 97: 2661-9, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 2/25/2014.